Trial Profile
Usage of Vinflunine i.v. (JAVLOR) for the Treatment of Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium in Adult Patients After Failure of a Cisplatinum-containing Therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2019
Price :
$35
*
At a glance
- Drugs Vinflunine (Primary)
- Indications Carcinoma; Urogenital cancer
- Focus Adverse reactions
- Acronyms JONAS-1
- Sponsors Pierre Fabre
- 27 Oct 2017 Results of post hoc subgroup (upper tract versus lower tract metastatic urothelial carcinomas) analysis published in the Anticancer Research
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 11 Dec 2013 Status changed from active, no longer recruiting to recruiting as reported by German Clinical Trials Register.